Finding The Right Talent
Robert E. Ward became Chairman and CEO at Eloxx Pharmaceuticals at a critical time. The company was growing rapidly, and was on the verge of launching two Phase 2 trials.
For our CEO Leadership Series, we talked to Mr. Ward about the unique challenges he faced when he stepped into his new role, and the unique potential of the products his company was developing.
“In biotechnology today, the biggest challenge is recruiting, retaining and engaging the right talent. Moving rapidly through the development of novel drugs requires effective working relationships with regulators, key opinion leaders, investigators, patient advocacy groups and a technology network that supports these programs.”
NOTE: This interview was conducted in 2018. While the interviewee’s position may have changed in the years since, the advice in this interview remains relevant and insightful!
Raising capital is at the core of any Life Sciences business. In a business where it can take years to see a profit, investor cash is king. Now that the infusion of funding from the pandemic has dried up and the economy faces an uncertain future, investors are reevaluating their choices.
It may be getting more difficult to attract investors to Life Sciences startups, but there are some key actions you can take to make your business more attractive. Here’s a great article from the Life Science Leader with important tips to draw investors to your business.